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Abstract SUNCT has been reported in association with
abnormalities of the brainstem and pituitary region. We
present a patient with a history of left optic nerve hypo-
plasia, mild hypothalamic-pituitary dysfunction, and
SUNCT starting in adolescence. SUNCT with an early age
of onset may be associated with congenital abnormality of
the hypothalamic-pituitary axis.
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Introduction
Short-lasting unilateral neuralgiform headache attacks with
conjunctival injection and tearing (SUNCT) was first
described in 1978 with diagnostic criteria established in
2004 [1, 2]. If associated with other cranial autonomic
symptoms or without both conjunctival injection and
tearing, the syndrome is classified as SUNA (short-lasting
unilateral neuralgiform headache attacks with autonomic
features) [3]. SUNCT and SUNA are classified as trigem-
inal autonomic cephalalgias along with cluster headaches,
and paroxysmal hemicrania with all of these headache
syndromes sharing unilateral headache pain in a V1 tri-
geminal distribution and ipsilateral activation of cranial
parasympathetics [2]. SUNCT has been reported in asso-
ciation with acquired and congenital abnormalities of the
brainstem and pituitary region [2]. We report a case of
SUNCT with onset in adolescence in a patient with uni-
lateral optic nerve hypoplasia (ONH) and mild hypotha-
lamic-pituitary dysfunction.
Case presentation
A 27-year-old Caucasian woman with a history of left
ONH diagnosed before 2 years of age was seen for eval-
uation of brief head pains. These headaches began at age
14. These head pains occurred over the right orbital region
and lasted for around 30 s and rarely for more than a
minute. The pain was described as sharp and severe. The
right eye became injected with tearing and right eyelid
edema also occurred during the headaches. The headaches
would occur three or more times per day for 2–3 days. The
patient would have this pattern of headaches 2–3 times per
year with no apparent seasonal or diurnal pattern. The
attacks appeared to be spontaneous with no clear triggers.
The episodes were relatively infrequent but were fright-
ening to the patient and her family. These had been pre-
viously considered a manifestation of anxiety.
The patient had a history of abnormal menstrual cycles
and galactorrhea starting in adolescence. The patient
reported having hyperprolactinemia but prolactin levels
from adolescence were not available for our review. In
adolescence, she was tried on bromocriptine that did not
adequately control her galactorrhea, but she had not had
galactorrhea over the preceding 3 years. She has a history of
two miscarriages although she completed three natural
pregnancies. The patient had elevated prolactin levels of 31.0
and 50.3 ng per milliliter (normal range 3.34–26.72 ng/ml)
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drawn at our facility and a low level of luteinizing hormone
0.76 milli-international units per milliliter (normal range
1.2–103.0 mIU/ml depending on stage of menstrual cycle)
with normal levels of follicle stimulating hormone, renin,
aldosterone, growth hormone, insulin-like growth factor-1,
adrenocorticotrophic hormone, and thyroid stimulating
hormone. Beginning in adolescence, the patient had spells
of brief confusion and autonomic symptoms felt to be
related to hypoglycemia with finger stick blood glucose
levels of 40–50 during or immediately after these spells. The
patient had a personal history of simple febrile seizures
occurring before age 2 with a family history of simple febrile
seizures in her father, twin brother, and in two of her children.
There is no other family member with documented ONH.
The patient had a normal developmental history and growth
velocity throughout childhood and adolescence.
Neurologic examination was remarkable for strabismus
and visual function limited to light perception in the left
eye. MRI of the Brain with and without contrast revealed a
hypoplastic left optic nerve (Fig. 1). The septum pelluci-
dum was present. An MRI of the sellar region with contrast
revealed an abnormality that followed the signal of cere-
brospinal fluid on T1 and T2 sequences without complete
attenuation on FLAIR sequences consistent with a pituitary
cyst (Fig. 1). The sellar region otherwise appeared normal
and there was no deviation of the infundibulum. A seizure
protocol MRI brain did not reveal any abnormalities sug-
gestive of a malformation of cortical development. No
abnormalities of the Meckel’s cave region or posterior
fossa were noted on any of these studies. An electroen-
cephalogram was within normal limits for age.
The patient has been followed for 8 months and con-
tinues to have a similar headache pattern. The patient’s
headaches are infrequent and unpredictable and determin-
ing an appropriate treatment strategy has been difficult.
The headaches do not occur frequently enough to require
preventive therapy. The patient is hesitant to start anti-
epileptic medications such as topiramate or lamotrigine, so
we prescribed indomethacin 25 mg to be used up to three
times per day during symptomatic periods with the goal of
reducing headache frequency and headache days. The
patient has not yet tried the medication.
Discussion
The patient’s headache syndrome met ICHD-2 criteria for
short-lasting, unilateral neuralgiform headaches with con-
junctival injection and tearing (SUNCT), and was consistent
with more recent descriptions of this syndrome [1–3]. This
Fig. 1 a Coronal T2 sequence
and b coronal FLAIR sequence
showing a small right pituitary
cyst and normal septum
pellucidum. c Coronal T1
sequence with gadolinium
showing a normal pituitary
gland and infundibulum.
d Coronal orbital inversion
recovery sequence showing left
optic nerve hypoplasia
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patient did not report cutaneous or other triggering factors as
seen in many SUNCT patients although spontaneous attacks
may be present in 14–28% of SUNCT patients [3]. The
clinical features were not suggestive of short-lasting
paroxysmal hemicrania or trigeminal neuralgia. We elected
a trial of indomethacin during symptomatic periods. The
efficacy of this therapeutic strategy has not yet been
determined.
SUNCT has been shown to have increased activation
in the hypothalamus ipsilateral to the symptoms and in
another case bilaterally on functional MRI [4, 5]. There is
also a case of SUNCT responding to hypothalamic stimu-
lation ipsilateral to the symptoms [6] and a case of a
SUNCT patient responding to treatment with clomiphene
citrate presumably due to its effects on the hypothalamus
[7]. There are numerous cases of SUNCT occurring in
patients with prolactinomas sometimes during treatment
with cabergoline or bromocriptine [8–13]. SUNCT has also
been in two patients with congenital bone abnormalities,
basilar impression and craniosynostosis, with presumed
involvement of the posterior fossa [14]. SUNCT typically
has age of onset between 35 and 65 years with a mean
around age 50 although ranges of age 10–77 have been
reported [2, 3]. SUNCT associated with pituitary or
brainstem abnormalities may have a slightly earlier age at
onset with a mean around age 43 in one review [14]. The
case of craniosynostosis had onset of SUNCT at age 14
similar to the age of onset in our patient suggesting that
congenital abnormalities of the posterior fossa or hypo-
thalamic-pituitary axis may precipitate an earlier age of
onset [15].
ONH is bilateral in 80% of cases [16]. Hypothalamic-
pituitary dysfunction occurs in 75% of patients with ONH
and hyperprolactinemia occurs in 62% of these patients
[16]. The pituitary gland is abnormal in only 13% of
patients with ONH and the septum pellucidum is absent in
38% of patients [16]. There may be a higher risk of
endocrine dysfunction in ONH patients with an absent
septum pellucidum and abnormal pituitary gland on neu-
roimaging but this is not absolute as patients without these
imaging features can still have hypothalamic-pituitary
dysfunction. Patients with unilateral ONH are at lower risk
of hypothalamic-pituitary dysfunction than those with
bilateral disease although dysfunction occurs in 69% of
patient’s with unilateral ONH (compared to 81% with
bilateral ONH) [16]. Our patient’s chronic hyperprolacti-
nemia, abnormal menstrual cycles, and presumed hypo-
glycemic episodes were suggestive of mild hypothalamic-
pituitary dysfunction. We were able to document hyper-
prolactinemia and low levels of luteinizing hormone, which
were the likely associated with her history of abnormal
menstrual cycles and galactorrhea. The strong personal and
family history of simple febrile seizures may indicate a
dysfunction of temperature regulation although another
heritable cause cannot be excluded. Problems with body
temperature regulation have been reported in ONH, pre-
sumably due to hypothalamic dysfunction, with these
patients sometimes requiring hospitalizations to rule out
infections [16]. Growth hormone deficiency and adreno-
corticotrophic hormone deficiency are among the most
common endocrinopathies in ONH patients, both of which
can result in hypoglycemia [16]. We were not able to
document a deficiency of growth hormone or adrenocorti-
cotrophic hormone to explain the episodes of presumed
hypoglycemia. Our patient had a pituitary abnormality on
MRI ipsilateral to her symptoms. The imaging character-
istics were most consistent with a pituitary cyst and there
was no other abnormality of her sellar region. We felt the
pituitary cyst was most likely an incidental finding and not
the likely cause of her mild hypothalamic dysfunction and
SUNCT headaches.
To our knowledge, this is the first reported case of
SUNCT in a patient with ONH. We hypothesize that there
is an association between SUNCT headaches and the mild,
hypothalamic-pituitary dysfunction in our patient. Con-
genital abnormality of the hypothalamic-pituitary axis may
also explain the onset of this headache syndrome in
adolescence.
Conflict of interest None.
References
1. Headache Classification Subcommittee of the International
Headache Society (2004) The international classification of
headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):9–160
2. Boes CJ, Swanson JW (2006) Paroxysmal hemicrania, SUNCT,
and hemicrania continua. Semin Neurol 26(2):260–270
3. Cohen AS, Matharu MS, Goadsby PJ (2006) Short-lasting uni-
lateral neuralgiform headache attacks with conjunctival injection
and tearing (SUNCT) or cranial autonomic features (SUNA)—a
prospective clinical study of SUNCT and SUNA. Brain
129(Pt 10):2746–2760
4. May A, Bahra A, Buchel C et al (1999) Functional MRI in
spontaneous attacks of SUNCT: short-lasting neuralgiform
headache with conjunctival injection and tearing. Ann Neurol
46:791–793
5. Sprenger T, Valet M, Platzer S et al (2005) SUNCT: bilateral
hypothalamic activation during headache attacks and resolving of
symptoms after trigeminal decompression. Pain 113(3):422–426
6. Leone M, Franzini A, D’Andrea G et al (2005) Deep brain
stimulation to relieve drug-resistant SUNCT. Ann Neurol
57(6):924–927
7. Rozen TD, Saper JR, Sheftell FD, Dodick DW (2005) Clomi-
phene citrate as a new treatment for SUNCT: hormonal manip-
ulation for hypothalamic-influenced trigeminal autonomic
cephalalgias. Headache 45(6):754–756
8. Matharu MS, Levy MJ, Merry RT, Goadsby PJ (2003) SUNCT
syndrome secondary to prolactinoma. J Neurol Neurosurg
Psychiatry 74(11):1590–1592
J Headache Pain (2009) 10:381–384 383
123
9. Massiou H, Launay JM, Levy C et al (2002) SUNCT syndrome in
two patients with prolactinomas and bromocriptine-induced
attacks. Neurology 58(11):1698–1699
10. Rozen TD (2006) Resolution of SUNCT after removal of a
pituitary adenoma in mild acromegaly. Neurology 67(4):724
11. Jime´nez Caballero PE (2007) SUNCT syndrome in a patient with
prolactinoma and cabergoline-induced attacks. Cephalalgia
27(1):76–78
12. Bosco D, Labate A, Mungari P et al (2007) SUNCT and high
nocturnal prolactin levels: some new unusual characteristics.
J Headache Pain 8(2):114–118
13. de Lourdes Figuerola M, Bruera O, Pozzo MJ, Leston J (2009)
SUNCT syndrome responding absolutely to steroids in two cases
with different etiologies. J Headache Pain 10(1):55–57
14. Trucco M, Mainardi F, Maggioni F et al (2004) Chronic parox-
ysmal hemicrania, hemicrania continua and SUNCT syndrome in
association with other pathologies: a review. Cephalalgia
24(3):173–184
15. Morı´s G, Ribacoba R, Solar DN, Vidal JA (2001) SUNCT syn-
drome and seborrheic dermatitis associated with craneosynosto-
sis. Cephalalgia 21:157–159
16. Borchert M, Garcia-Filion P (2008) The syndrome of optic nerve
hypoplasia. Curr Neurol Neurosci Rep 8(5):395–403
384 J Headache Pain (2009) 10:381–384
123
